Welf Prager

945 total citations
45 papers, 654 citations indexed

About

Welf Prager is a scholar working on Dermatology, Neurology and Surgery. According to data from OpenAlex, Welf Prager has authored 45 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Dermatology, 23 papers in Neurology and 9 papers in Surgery. Recurrent topics in Welf Prager's work include Botulinum Toxin and Related Neurological Disorders (22 papers), Facial Rejuvenation and Surgery Techniques (21 papers) and Dermatologic Treatments and Research (19 papers). Welf Prager is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (22 papers), Facial Rejuvenation and Surgery Techniques (21 papers) and Dermatologic Treatments and Research (19 papers). Welf Prager collaborates with scholars based in Germany, United States and Estonia. Welf Prager's co-authors include I. Zschocke, Martina Kerscher, Volker Steinkraus, Rolf‐Markus Szeimies, Sigrid Karrer, Wolfgang G. Philipp‐Dormston, Elisabeth Kohl, Thomas Rappl, Gerd G. Gauglitz and Bianca Kollhorst and has published in prestigious journals such as Journal of the European Academy of Dermatology and Venereology, Journal of Cardiovascular Pharmacology and Dermatologic Surgery.

In The Last Decade

Welf Prager

44 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Welf Prager Germany 16 501 338 103 89 72 45 654
Philippa Lowe United Kingdom 11 487 1.0× 246 0.7× 144 1.4× 86 1.0× 28 0.4× 16 657
Larry Buchner United States 16 648 1.3× 325 1.0× 203 2.0× 59 0.7× 18 0.3× 20 807
Rainer Pooth Germany 17 724 1.4× 362 1.1× 270 2.6× 69 0.8× 21 0.3× 39 936
Ursula Benter Germany 7 261 0.5× 161 0.5× 89 0.9× 42 0.5× 17 0.2× 9 390
ROMAN GOERTELMEYER Germany 13 325 0.6× 254 0.8× 98 1.0× 40 0.4× 9 0.1× 13 499
William Philip Werschler United States 15 511 1.0× 125 0.4× 141 1.4× 97 1.1× 36 0.5× 35 671
Daniel Cassuto Italy 18 704 1.4× 342 1.0× 236 2.3× 46 0.5× 25 0.3× 33 824
Daniel P. Friedmann United States 14 395 0.8× 48 0.1× 208 2.0× 45 0.5× 55 0.8× 60 555
Luitgard Wiest Germany 11 387 0.8× 188 0.6× 141 1.4× 24 0.3× 30 0.4× 24 465
Taciana Dal’Forno Brazil 12 236 0.5× 146 0.4× 196 1.9× 78 0.9× 20 0.3× 23 423

Countries citing papers authored by Welf Prager

Since Specialization
Citations

This map shows the geographic impact of Welf Prager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Welf Prager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Welf Prager more than expected).

Fields of papers citing papers by Welf Prager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Welf Prager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Welf Prager. The network helps show where Welf Prager may publish in the future.

Co-authorship network of co-authors of Welf Prager

This figure shows the co-authorship network connecting the top 25 collaborators of Welf Prager. A scholar is included among the top collaborators of Welf Prager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Welf Prager. Welf Prager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sattler, Gerhard, Martina Kerscher, Ernst Magnus Noah, et al.. (2020). <p>Safety and Performance of Etermis 3 and 4 in Wrinkles/Folds Treatment and Facial Volume Enhancement: A Prospective, Evaluator-Blinded, Open-Label Study</p>. Clinical Cosmetic and Investigational Dermatology. Volume 13. 591–599.
2.
Karrer, Sigrid, Rolf‐Markus Szeimies, Wolfgang G. Philipp‐Dormston, et al.. (2020). Repetitive Daylight Photodynamic Therapy versus Cryosurgery for Prevention of Actinic Keratoses in Photodamaged Facial Skin: A Prospective, Randomized Controlled Multicentre Two-armed Study. Acta Dermato Venereologica. 101(1). adv00355–adv00355. 8 indexed citations
3.
Kerscher, Martina, et al.. (2017). Effectiveness evaluation of two volumizing hyaluronic acid dermal fillers in a controlled, randomized, double-blind, split-face clinical study. Clinical Cosmetic and Investigational Dermatology. Volume 10. 239–247. 23 indexed citations
5.
Rubin, Mark G., et al.. (2016). Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review. Clinical Cosmetic and Investigational Dermatology. Volume 9. 257–280. 38 indexed citations
6.
Pavicic, Tatjana, et al.. (2015). IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study. Clinical Cosmetic and Investigational Dermatology. 8. 135–135. 12 indexed citations
8.
Prager, Welf, et al.. (2014). IncobotulinumtoxinA for the Treatment of Platysmal Bands. Dermatologic Surgery. 41(Supplement 1). S88–S92. 19 indexed citations
9.
Peacock, Sharon J. & Welf Prager. (2013). Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines. Clinical Pharmacology Advances and Applications. 5. 39–39. 10 indexed citations
10.
12.
Karrer, Sigrid, Elisabeth Kohl, S. Lischner, et al.. (2013). Photodynamische Therapie zur Hautverjüngung: Übersicht und publizierte Datenlage – Ergebnisse einer Konsensus‐Konferenz des Arbeitskreises Ästhetische Photodynamische Therapie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 11(2). 137–148. 2 indexed citations
13.
Karrer, Sigrid, Elisabeth Kohl, S. Lischner, et al.. (2012). Photodynamic therapy for skin rejuvenation: review and summary of the literature – results of a consensus conference of an expert group for aesthetic photodynamic therapy. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 11(2). 137–148. 42 indexed citations
15.
Prager, Welf, et al.. (2012). Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice. Clinical Cosmetic and Investigational Dermatology. 5. 53–53. 15 indexed citations
16.
Prager, Welf, et al.. (2011). Botulinumtoxin Typ A im Halbseitenvergleich. Der Hautarzt. 62(5). 375–379. 6 indexed citations
17.
Rzany, Berthold, Said Hilton, Welf Prager, et al.. (2010). Expert guideline on the use of porcine collagen in aesthetic medicine. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 8(3). 210–216. 10 indexed citations
18.
Prager, Welf, et al.. (2010). Comparison of Two Botulinum Toxin Type A Preparations for Treating Crow's Feet: A Split-Face, Double-Blind, Proof-of-Concept Study. Dermatologic Surgery. 36(Supplement 4). 2155–2160. 44 indexed citations
19.
Prager, Welf, et al.. (2009). Beeinflusst die Verdünnung das kosmetische Ergebnis von BoNT/A?: Komplexproteinfreies BoNT/A zur Behandlung der Glabellafalte. Der Hautarzt. 60(10). 815–820. 1 indexed citations
20.
Prager, Welf, et al.. (2009). Stellenwert der Oberlidkorrektur in der Dermatochirurgie. Der Hautarzt. 60(7). 550–555. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026